This Article  • References  • Full text PDF  • Correction  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

John E. Franklin, MD

JAMA. 1993;270(2):184-185.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The health care debates of 1993 highlight the need for better knowledge of service utilization patterns, treatment effectiveness, and cost-effectiveness of health care. Addiction medicine will be increasingly challenged to provide highquality, cost-effective treatments to maximize the effectiveness of health care expenditures in this area. Updated 1-year prevalence data from the Epidemiologic Catchment Area Program report that specialists in mental and addictive disorders provide treatment for 5.9% of the US population, and only 28.5% of people with mental or addictive disorders seek treatment.¹ Over 30 million persons are uninsured in this country. A significant percentage of alcohol and drug abusers fall into this category. The extent to which addiction treatment services would be available in a climate of managed competition is unclear and concerning.

Few studies specifically address cost-effectiveness of treatment. Goodman et al,² in an analysis of short-term treatment costs, highlighted the complexity of cost analysis research . . . [Full Text PDF of this Article]

Author Affiliations
Northwestern University Medical School, Chicago, Ill

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?